Victims of transvaginal mesh failures that have caused serious health problems may have noticed reports on the Internet about a few case in which it has been reported that a few trials have been held already over these failures.
The reports say that while there have not been many such trials, verdicts of over $1 million have been returned in favor of the victims. Legal experts say these case may just be the tip of an iceberg.
While the Food and Drug Administration has been content to just issue Safety Communications about the dangers of transvaginal mesh — even as the agency received nearly 3,000 complaints in a two-year period — transvaginal mesh victims are taking a more active approach in our court system.
There have been so many transvaginal mesh lawsuits filed against such large pharmaceutical companies such as American Medical Systems (AMS), Boston Scientific, Ethicon and others that federal court district officials have been forced to consolidate them into multi-district litigations.
That is the first step in what could evolve into massive class-action cases against the manufacturers. It is not uncommon for such cases to generate eventual settlements and jury awards in the hundreds of millions of dollars.
First, however, the judge involved must coordinate legal proceedings that include evidence-gathering and then schedule bellwether, or test trials, in which lawyers for the transvaginal mesh victims and the manufacturers test the strength of their cases.
Those trials were recently put on the court calendar and scheduled to begin by the end of the year. Transvaginal mesh lawyers have announced that victims of transvaginal mesh failures and problems are still eligible to join in the litigation and free consultations are being offered.
These trials will focus on the safety of transvaginal meshes, which are implanted through surgery for the treatment of urinary incontinence and pelvic organ prolapse (POP), two afflictions common to women as they age and their abdominal muscles weaken.
The lawyers for victims of transvaginal mesh problems will argue that these devices used to support organs in the pelvic region of women were not adequately tested and that the manufacturers did not properly inform patients of the possibility of painful side effects.
Among the most common side effects cited in these allegations are pain, erosion, bleeding, infection, and the inability to enjoy normal sexual intercourse.